Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers

Ignace Vergote, B. Lund, H. Havsteen, Z Ujmajuridze, Els Van Nieuwenhuysen, C. Haslund, T. Juhler-Nottrup, Patrick Neven, M. Mau-Sorensen, P. Berteloot, Anne L Kranich, T Rashal, J. Meade, Yosef Landesman, Jean-Richard Saint-Martin, George Wright, M. Crochiere, S Shacham, M Kauffman, M. R. Mirza

Research output: Contribution to journalConference abstract in journalResearchpeer-review

1 Citation (Scopus)
Original languageEnglish
Article number8540O
JournalAnnals of Oncology
Issue numberSuppl. 6
Publication statusPublished - 2016
Event41st ESMO Congress: From disease treatment to patient care - København, Denmark
Duration: 7 Oct 201611 Oct 2016
Conference number: 41


Conference41st ESMO Congress
Internet address

Bibliographical note

ISI Document Delivery No.: EK4QS Times Cited: 0 Cited Reference Count: 0 Vergote, I. Lund, B. Havsteen, H. Ujmajuridze, Z. Van Nieuwenhuysen, E. Haslund, C. Juhler-Nottrup, T. Neven, P. Mau-Sorensen, M. Berteloot, P. Kranich, A. Rashal, T. Meade, J. Landesman, Y. Saint-Martin, J-R. Wright, G. Crochiere, M. Shacham, S. Kauffman, M. Mirza, M. Raza Karyopharm Therapeutics 0 Oxford univ press Oxford 1569-8041 6


  • Oncology

Cite this